BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38783033)

  • 1. Integrated analysis identified the role of three family members of ARHGAP in pancreatic adenocarcinoma.
    Fei H; Shi X; Sun D; Yang H; Wang D; Li K; Si X; Hu W
    Sci Rep; 2024 May; 14(1):11790. PubMed ID: 38783033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma.
    Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H
    Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
    Yan C; Niu Y; Li F; Zhao W; Ma L
    J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 6. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
    PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
    Wang L; Zhang S; Li H; Xu Y; Wu Q; Shen J; Li T; Xu Y
    BMC Cancer; 2021 Jul; 21(1):876. PubMed ID: 34332578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
    Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
    Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
    Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
    BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LINC01232 Sponges Multiple miRNAs and Its Clinical Significance in Pancreatic Adenocarcinoma Diagnosis and Prognosis.
    Du W; Lei C; Wang Y; Ding Y; Tian P
    Technol Cancer Res Treat; 2021; 20():1533033820988525. PubMed ID: 33506742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis.
    Tian C; Li X; Ge C
    Mol Med; 2021 Jun; 27(1):62. PubMed ID: 34134622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
    Li F; Zhang P
    Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
    Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
    Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics analysis identified MMP14 and COL12A1 as immune-related biomarkers associated with pancreatic adenocarcinoma prognosis.
    Li Y; Su Z; Wei B; Qin M; Liang Z
    Math Biosci Eng; 2021 Jun; 18(5):5921-5942. PubMed ID: 34517516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between a 7-mRNA signature of the pancreatic adenocarcinoma microenvironment and patient prognosis (a STROBE-compliant article).
    He QL; Jiang HX; Zhang XL; Qin SY
    Medicine (Baltimore); 2020 Jul; 99(29):e21287. PubMed ID: 32702921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma.
    Zhong B; Ma DD; Zhang T; Gong Q; Dong Y; Zhang JX; Li ZH; Jin WD
    Comb Chem High Throughput Screen; 2024; 27(7):1011-1021. PubMed ID: 37563820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
    Luo L; Zhang G; Wu T; Wu G
    Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma.
    Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X
    BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
    Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
    Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.